Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

AARTI PHARMALABS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 15.1210.707.811.22-3.76

What is the latest EV/Core EBITDA ratio of AARTI PHARMALABS ?

The latest EV/Core EBITDA ratio of AARTI PHARMALABS is 15.12 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202515.12
Mar202410.70
Mar20237.81
Mar20221.22
Mar2021-3.76

How is EV/Core EBITDA of AARTI PHARMALABS Trending?

Years EV/Core EBITDA % Change
Mar2025 15.12
41.31
Mar2024 10.7
37.00
Mar2023 7.81
540.16
Mar2022 1.22
Positive
Mar2021 -3.76 -

Other Financial Ratios of AARTI PHARMALABS


Compare EV/Core EBITDA ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹6,451.5 Cr -8.5% -7.2% 10.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,402.0 Cr 1.2% -0.9% -1.8% Stock Analytics
DIVIS LABORATORIES ₹164,277.0 Cr 2.7% -3.8% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,140.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹107,398.0 Cr -0.1% -8.2% -8.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,378.0 Cr 2.7% 7.1% 2.8% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-8.5%

-7.2%

10.8%

SENSEX

0.4%

-0.2%

6.9%


You may also like the below Video Courses